Pharmaceutical giants introduce an insurance-free pathway for top anticoagulant Eliquis, following similar direct-to-patient ...

The joint venture is launching a direct-to-consumer service of Eliquis after discussions with the Trump administration.

Drugmakers will offer Eliquis at a 43% discount to uninsured U.S. patients, bypassing insurers and PBMs New $346 monthly ...

(Reuters) -US drugmakers Bristol Myers and Pfizer said on Thursday that they will make their blood thinner, Eliquis, ...

Taking a page from Eli Lilly and Novo Nordisk, who have launched online programs to sell their diabetes and obesity drugs ...

Many studies have shown that even though these medicines have risks, these risks are much lower than the risk of a stroke ...

Bristol Myers and Pfizer will sell Eliquis directly to U.S. patients at a discounted rate with transparent pricing and ...

In advance of CMS’ negotiated price for the blood thinner taking effect next year, partners Bristol Myers Squibb and Pfizer ...

Pfizer and Bristol Myers Squibb have launched a direct-to-patient program offering their blood thinner Eliquis at a 40% discount for cash-paying patients.  The list price for Eliquis (apixaban) is ...

The program is the latest example of pharmaceutical companies bypassing traditional drug distribution channels for people who ...

Eliquis’ efficacy in preventing strokes proved about as good as Pradaxa’s and slightly better than Xarelto’s. Pradaxa, which like Eliquis is dosed twice daily, demonstrated superior efficacy but not ...

CVS Health's move to drop Eliquis comes as the insurer's pharmacy benefit manager increasingly removes drugs from its formulary, excluding 433 products in 2022, up from 417 the year before.